BioCentury | Jun 15, 2018
Company News

BridgeBio launches rare genetic disorder subsidiary

...a mutant PANK2 gene, has Fast Track and Orphan Drug designation in the U.S. P-PantSAc (TM-1803...
BioCentury | Jun 13, 2018
Company News

BridgeBio launches rare genetic disorder subsidiary

...a mutant PANK2 gene, has Fast Track and Orphan Drug designation in the U.S. P-PantSAc (TM-1803...
...pharma and houses them in individual subsidiaries (see BioCentury, Sept. 15, 2017) . Chris Lieu fosmetpantotenate (RE-024) P-PantSAc (TM-1803) BridgeBio...
Items per page:
1 - 2 of 2